Viatcheslav R Akmaev

This inventor holds 13 USPTO granted patents and 16 published patent applications and 2 EPO patents. Top assignees: Scipher Medicine Corporation, Bpgbio, Inc., Berg LLC. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viatcheslav R Akmaev. Retrieved from https://idiyas.com/inventor/viatcheslav-r-akmaev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 16)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

6 out of 9

Scipher Medicine Corporation

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12626169 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2026-05-12),

2. 12525318 - Method of monitoring anti-TNF therapy in a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier (2026-01-13),

3. 12320812 - Markers for the diagnosis of biochemical recurrence in prostate cancer (2025-06-03),

4. 12062415 - Methods of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based in part on a trained machine learning classifier (2024-08-13),

5. 12046338 - Assessing responsiveness to therapy (2024-07-23),

6. 11866487 - Filamin A binding proteins and uses thereof (2024-01-09),

7. 11783913 - Methods of treating a subject suffering from rheumatoid arthritis with alternative to anti-TNF therapy based in part on a trained machine learning classifier (2023-10-10),

8. 11734593 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2023-08-22),

9. 11456056 - Methods of treating a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier (2022-09-27),

10. 11195595 - Method of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based on a trained machine learning classifier (2021-12-07),

11. 10759850 - Filamin A binding proteins and uses thereof (2020-09-01),

12. 10539566 - Use of markers including filamin A in the diagnosis and treatment of prostate cancer (2020-01-21),

13. 10482385 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2019-11-19),

Title: Innovations of Viatcheslav R Akmaev: A Pioneer in Biochemical Diagnostics and Treatments

Introduction

Viatcheslav R Akmaev is a notable inventor based in Sudbury, MA, known for his significant contributions to the fields of biomedical diagnostics and therapeutic methods. With a remarkable portfolio of 11 patents, Akmaev's work focuses primarily on advancing the diagnosis and treatment of serious health conditions, particularly prostate cancer and rheumatoid arthritis.

Latest Patents

Among his latest innovations, one of Akmaev's prominent patents is related to the development of markers for the diagnosis of biochemical recurrence in prostate cancer. This invention encompasses methods for diagnosing the presence of biochemical recurrence (BCR) in subjects by detecting levels of various biomarkers indicative of BCR. In addition, he has created compositions in the form of kits and panels of reagents aimed at detecting these critical biomarkers.

Another noteworthy patent involves methods of treating subjects suffering from rheumatoid arthritis through anti-TNF therapy, which utilizes a trained machine learning classifier. This innovative approach allows for predicting responses to specific treatments, thereby enabling personalized care for patients. The method identifies subjects who may benefit from alternatives to anti-TNF therapy based on their historical response patterns.

Career Highlights

Throughout his career, Akmaev has engaged with leading companies that focus on medical innovations. Notably, he has worked at Scipher Medicine and Berg LLC, where his expertise has contributed to pioneering research and development in biomedical technology. His work continues to influence the landscape of healthcare solutions, reinforcing the importance of precision medicine.

Collaborations

Akmaev has collaborated with esteemed colleagues, including Theodore R Mellors and Marc Santolini. These partnerships illustrate the collaborative spirit of innovation, where interdisciplinary efforts foster the advancement of medical technologies.

Conclusion

Viatcheslav R Akmaev stands out as a vital contributor to the fields of biomedical innovation and patient care. With a focus on critical health issues and the application of advanced technologies like machine learning, his work not only enhances diagnostic methods and treatment efficiencies but also represents a significant step forward in personalized medicine. His contributions continue to impact both the scientific community and patients alike, paving the way for future breakthroughs in healthcare.

Profile summary based on public USPTO records.